Introduction/Background In low income countries and in the absence of national preventive programs (generalized HPV vaccination and population screening), most cases of cervical cancer are locally advanced with a high mortality and morbidity. The purpose of this study was to evaluate the epidemic profile and the prognosis of cervical cancer in women ≤40 in Tunisia
Methodology It is a retrospective mono-centric study from January 2010 to January 2021. We evaluated the clinical history, treatment, and follow-up of all women ≤40 years of age diagnosed with cervical cancer, from a global cohort of 493 patients diagnosed in our center with cervical cancer during the same period.
Results We included 29 patients. The prevalence of cervical cancer among women ≤40 is 5.88%. The mean age was 34,7 ±4,7 years. Ten patients (43.4%) did not attend high school. Fifteen (65.2%) were unemployed. Nineteen (82.6%) were married of whom 4 were nulliparous. The mean age of first sexual intercourse was 21.5 years [20–26]. The diagnosis of cervical carcinoma was made on screening pap smear in 14 cases (60.8%). The average tumor size was 45 mm (± 18.7), while on MRI average tumor size was 56.75 mm (± 18.4).According to the FIGO classification: 30.4% had non-invasive cancer and 18.6% had stage I. Nine patients had a hysterectomy (5 initially and 4 after concomittant chemoradiation). After a 5 year follow up 21.7% of women died of cervical cancer.
Conclusion Cervical cancer is a rare entity in woman ≤40. Locally advanced stage disease is prevalent with a poor prognosis at 5 years.
Disclosures Nothing to declare
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.